JCR Pharmaceuticals Co Ltd 2023 IR
The report outlines JCR Pharmaceuticals' progress on its growth strategy and sustainability initiatives under its Midterm Business Plan for FY2023-2027, 'Reach Beyond, Together.' Key highlights include the completion of the Kobe Science Park Center, a new API plant equipped with single-use culture vessels, and the establishment of JCR Luxembourg S.A. as a European logistics hub. The company advanced its rare disease pipeline, initiating global clinical trials for several lysosomal storage disorder treatments utilizing its proprietary J-Brain Cargo technology. Additionally, JCR successfully expanded its production of GROWJECT to meet market demand and continued its commitment to diversity, achieving a 12.5% ratio of female managers and a 67% male childcare leave acquisition rate.
Company: JCR Pharmaceuticals Co Ltd
Sector: Health Care
Country: Japan
Year: 2023
Type: IR
Pages: 96
JCR Pharmaceuticals Co Ltd
Corporate Report
The report outlines JCR Pharmaceuticals' progress on its growth strategy and sustainability initiatives under its Midterm Business Plan for FY2023-2027, 'Reach Beyond, Together.' Key highlights include the completion of the Kobe Science Park Center, a new API plant equipped with single-use culture vessels, and the establishment of JCR Luxembourg S.A. as a European logistics hub. The company advanced its rare disease pipeline, initiating global clinical trials for several lysosomal storage disorder treatments utilizing its proprietary J-Brain Cargo technology. Additionally, JCR successfully expanded its production of GROWJECT to meet market demand and continued its commitment to diversity, achieving a 12.5% ratio of female managers and a 67% male childcare leave acquisition rate.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2022
Published
Nov 1, 2023
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Women in Management
Employees